Michael Sean Marcin, MD, MSCR
Neurodevelopmental Disabilities · Mountain View
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Marcin’s office at (650) 446-4900 to ask if they take your plan before you enroll.
California Medical Board record
Licence C55101 · Current
Licensed to practise in California · since 2012 · expires 2027-09-30 · Saint Louis University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Washington MD.MD.61213218Physician And Surgeon License · since 2021 · expires 2028-09-10ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Child and Adolescent Psychiatry
- American Board of Psychiatry and Neurology - Psychiatry
Drugs they prescribed that Part D paid
$221
Pharmacies billed $221 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 18) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
18 generic and 0 brand-name prescriptions · $221 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 18 | None | 0% (0) | 0% | $221 |
| 2023 | 12 | None | 0% (0) | 0% | $379 |
| 2022 | 43 | 11 | 0% (0) | None | $23,331 |
| 2021 | 248 | 38 | 0% (0) | 10% | $58,755 |
| 2020 | 157 | 21 | 0% (0) | 7% | $13,606 |
| 2019 | 155 | 20 | 0% (0) | None | $12,065 |
| 2018 | 162 | 36 | 0% (0) | 10% | $11,952 |
| 2017 | 193 | 39 | 0% (0) | 9% | $9,788 |
| 2016 | 192 | 44 | None | 9% | $5,954 |
| 2015 | 318 | 44 | None | None | $35,835 |
| 2014 | 460 | 25 | 0% (0) | 37% | $100,168 |
| 2013 | 557 | 28 | 0% (0) | 35% | $107,730 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 8 drugs
| Invega Sustenna | 14 | $42,196 | $3,014 |
| Guanfacine Hcl Er | 14 | $1,674 | $120 |
| Bupropion Xl | 21 | $1,560 | $74 |
| Aripiprazole | 22 | $924 | $42 |
| Escitalopram | 17 | $293 | $17 |
| Olanzapine | 14 | $214 | $15 |
| Mirtazapine | 11 | $177 | $16 |
| Fluoxetine | 14 | $150 | $11 |
2020: 5 drugs
| Aripiprazole | 16 | $2,039 | $127 |
| Guanfacine Hcl Er | 12 | $1,654 | $138 |
| Bupropion Xl | 13 | $1,130 | $87 |
| Dextroamphetamine-Amphetamine | 11 | $252 | $23 |
| Escitalopram | 14 | $140 | $10 |
2019: 4 drugs
| Guanfacine Hcl Er | 15 | $4,631 | $309 |
| Bupropion Xl | 13 | $483 | $37 |
| Escitalopram | 23 | $450 | $20 |
| Dextroamphetamine-Amphet Er | 11 | $293 | $27 |
2018: 2 drugs
| Risperidone | 11 | $206 | $19 |
| Escitalopram | 15 | $107 | $7 |
2017: 2 drugs
| Gabapentin | 12 | $778 | $65 |
| Risperidone | 19 | $255 | $13 |
2016: 4 drugs
| Mirtazapine | 13 | $204 | $16 |
| Quetiapine | 12 | $164 | $14 |
| Risperidone | 22 | $116 | $5 |
| Trazodone | 11 | $69 | $6 |
2015: 6 drugs
| Abilify | 36 | $21,668 | $602 |
| Quetiapine | 20 | $369 | $18 |
| Risperidone | 52 | $320 | $6 |
| Propranolol | 15 | $298 | $20 |
| Paroxetine | 13 | $219 | $17 |
| Sertraline | 22 | $95 | $4 |
2014: 15 drugs
| Abilify | 84 | $59,782 | $712 |
| Invega Sustenna | 13 | $24,100 | $1,854 |
| Quetiapine | 40 | $10,299 | $257 |
| Trifluoperazine | 14 | $962 | $69 |
| Risperidone | 95 | $950 | $10 |
| Gabapentin | 11 | $810 | $74 |
| Escitalopram | 16 | $645 | $40 |
| Paroxetine | 22 | $634 | $29 |
| Propranolol | 28 | $616 | $22 |
| Sertraline | 40 | $407 | $10 |
| Lithium Carbonate | 16 | $285 | $18 |
| Fluphenazine | 15 | $210 | $14 |
| Lorazepam | 19 | $75 | $4 |
| Trihexyphenidyl | 13 | $65 | $5 |
| Clonidine | 12 | $62 | $5 |
2013: 14 drugs
| Abilify | 75 | $51,877 | $692 |
| Invega Sustenna | 12 | $21,749 | $1,812 |
| Quetiapine | 56 | $16,184 | $289 |
| Escitalopram | 39 | $3,678 | $94 |
| Risperidone | 90 | $2,217 | $25 |
| Gabapentin | 12 | $685 | $57 |
| Propranolol | 44 | $664 | $15 |
| Sertraline | 45 | $523 | $12 |
| Paroxetine | 27 | $409 | $15 |
| Lithium Carbonate | 20 | $259 | $13 |
| Fluphenazine | 12 | $216 | $18 |
| Clonazepam | 36 | $215 | $6 |
| Lorazepam | 26 | $152 | $6 |
| Benztropine Mesylate | 12 | $75 | $6 |
Professional record
- NPI
- 1528100021
- Licence
- CA C 55101, GA 049407, NY 314609-01, OR MD26579, WA MD.61213218California C55101: Current · expires 2027-09-30Washington MD.MD.61213218: Active
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2084P0005X (2084P0005X); Federal specialty code 2084P0804X (2084P0804X)
- Mailing address
- 298 San Antonio Rd Ste 100, Mountain View, CA, 94040
- NPI first listed
- 2007-02-12
- NPI last updated
- 2024-04-16
- NPI record certified
- 2024-04-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 4530 Union Bay Pl Ne, Seattle, WA, 98105